Clinical Trial

Identification of Histories of Pregnancy Termination, Particularly Early Miscarriage, in General Medical Records

Completed
View on ClinicalTrials.gov →
Summary
Early miscarriage (EM) is defined as the spontaneous expulsion of an intrauterine pregnancy of less than 14 weeks' duration. Early miscarriage is a very common complication, affecting more than 10% of pregnancies. Because of its frequency, EM is often considered a trivial event, particularly by healthcare professionals. However, for the women who experience it, EM can be a traumatic event, difficult to discuss with their families, and a source of worries and questions for subsequent pregnancies. The international literature is consistent on the psychological morbidity associated with miscarriage: anxiety, depression and post-traumatic stress disorder have been studied in women following CPT. The identification of a history of EM by doctors is therefore important for the overall management of women's health. The 2021 National Perinatal Survey showed that less than 5% of pregnant women in France had their first six months of pregnancy monitored by a general practitioner, a proportion that has been steadily declining in recent years. The majority of women are monitored by a gynecologist, or in 40% of cases by a midwife. These professionals therefore appear to be the preferred point of contact for women in the event of a miscarriage. In the absence of specific information, either from the woman herself or from the healthcare professional who treated her, the general practitioner-the attending physician may remain unaware of this event in their patient's life. Under these circumstances, identifying a history of EM in the general practitioner's medical records may not be sufficient.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-05.
Trial Details
NCT Number NCT07406776
Lead Sponsor Université de Reims Champagne-Ardenne
Conditions Early Miscarriage
Enrollment 145 participants
Start Date 2025-05-16
Primary Completion 2025-11-27 (estimated)
Study Completion 2026-02-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-17